The role of chromogranin A in the management of patients with phaeochromocytoma

@article{Grossrubatscher2006TheRO,
  title={The role of chromogranin A in the management of patients with phaeochromocytoma},
  author={E. Grossrubatscher and P. Dalino and F. Vignati and M. Gambacorta and R. Pugliese and M. Boniardi and O. Rossetti and A. Marocchi and M. Bertuzzi and P. Loli},
  journal={Clinical Endocrinology},
  year={2006},
  volume={65}
}
  • E. Grossrubatscher, P. Dalino, +7 authors P. Loli
  • Published 2006
  • Medicine
  • Clinical Endocrinology
  • Objective  Chromogranin A (CgA) is the most accurate general marker of neuroendocrine tumours. Supranormal CgA concentrations have been recorded in patients with tumours of neuroectodermal origin such as phaeochromocytoma and paraganglioma. 
    61 Citations
    Pheochromocytoma: Unmasking the Chameleon
    • 5
    [Diagnostic approach of pheochromocytomas and paragangliomas].
    [Chromogranin A and neuroendocrine tumors].
    • 3
    • PDF
    Treatment of malignant pheochromocytoma.
    • 89

    References

    SHOWING 1-10 OF 27 REFERENCES
    The value of plasma markers for the clinical behaviour of phaeochromocytomas.
    • 83
    • PDF
    Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
    • 202
    • PDF
    Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma.
    • 56
    • PDF
    Diagnostic specificity of serum chromogranin-A for pheochromocytoma in patients with renal dysfunction.
    • 53